- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death ; volume:20 ; number:1 ; day:4 ; month:12 ; year:2020 ; pages:1-15 ; date:12.2020
BMC cancer ; 20, Heft 1 (4.12.2020), 1-15, 12.2020
- Creator
-
Heo, Sook-Kyoung
Noh, Eui-Kyu
Yu, Ho-Min
Kim, Do Kyoung
Seo, Hye Jin
Lee, Yoo Jin
Cheon, Jaekyung
Koh, Su Jin
Min, Young Joo
Choi, Yunsuk
Jo, Jae-Cheol
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07701-8
- URN
-
urn:nbn:de:101:1-2021011319145041905454
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heo, Sook-Kyoung
- Noh, Eui-Kyu
- Yu, Ho-Min
- Kim, Do Kyoung
- Seo, Hye Jin
- Lee, Yoo Jin
- Cheon, Jaekyung
- Koh, Su Jin
- Min, Young Joo
- Choi, Yunsuk
- Jo, Jae-Cheol
- SpringerLink (Online service)
Other Objects (12)
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota
Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Correction: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota
Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Correction: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota
Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Correction: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4